Sunshine Biopharma, Inc. has contracted Beta Pharma Canada, Inc. to manufacture an initial batch of its Adva-27a cancer drug and provide synthesis parameters for future scale-up and large scale manufacturing of the drug.   Beta Pharma Canada, Inc., headquartered in Montreal, is an affiliate of Beta Pharma, Inc. with offices and facilities in Connecticut and Shanghai. Adva-27a is Sunshine’s lead anti-cancer compound, which has been proven effective in killing Multidrug Resistant Breast Canc...